Related Experiment Video
Updated: Jan 2, 2026
09:33
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.3K
Peripheral Blood-Derived Microglia-Like Cells Decrease Amyloid-β Burden and Ameliorate Cognitive Impairment in a
Eriko Kuroda1, Kazuyuki Takata2, Kaneyasu Nishimura2
1Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, Japan.
Journal of Alzheimer'S Disease : JAD
|December 5, 2019
Summary
Peripheral blood stem cells can be differentiated into microglia-like cells for Alzheimer's disease (AD) therapy. These cells clear amyloid-beta plaques and improve cognition in AD mouse models, offering a promising new treatment avenue.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Amyloid-beta (Aβ) accumulation drives Alzheimer's disease (AD) pathogenesis.
- Microglia are crucial for clearing Aβ via phagocytosis.
- Current cell therapies for AD require invasive methods for cell preparation.
Purpose of the Study:
- To develop a less invasive method for generating autologous microglia-like cells for AD therapy.
- To investigate the potential of peripheral blood-derived microglia-like (PBDML) cells in an AD mouse model.
Main Methods:
- Mobilized hematopoietic stem cells from peripheral blood were differentiated into PBDML cells using specific growth factors (CSF-1 and IL-34).
- PBDML cells were characterized for microglial markers and Aβ phagocytosis capacity.
- PBDML cells were injected into the hippocampus of an AD mouse model to assess survival, Aβ clearance, and cognitive function.
Main Results:
- PBDML cells expressed microglial markers and phagocytosed Aβ.
- In vitro, PBDML cells exhibited both anti-inflammatory and pro-inflammatory responses.
- In vivo, PBDML cells survived, reduced Aβ burden, and ameliorated cognitive deficits in AD mice for at least 36 days.
Conclusions:
- PBDML cells represent a viable, less invasive source for autologous cell therapy in AD.
- This approach holds significant promise for developing novel therapeutic strategies against Alzheimer's disease.
